Multiple antipsychotics use in patients with schizophrenia: Why do we use it, what are the results from patient follow-ups?

Kahve A. C., Kaya H., Cakil A. G., Bicakci E. U., Goksel P., Goka E., ...Daha Fazla

ASIAN JOURNAL OF PSYCHIATRY, cilt.52, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 52
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.ajp.2020.102063
  • Dergi Adı: ASIAN JOURNAL OF PSYCHIATRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Psycinfo
  • Anahtar Kelimeler: Schizophrenia, Inpatient, Multiple antipsychotics, Antipsychotic combination, PSYCHIATRY WFSBP GUIDELINES, LONG-TERM TREATMENT, BIOLOGICAL TREATMENT, WORLD FEDERATION, META-REGRESSION, PART 2, POLYPHARMACY, RISK, ADOLESCENTS, RISPERIDONE
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

In this study, the rates of antipsychotic polypharmacy, factors affecting combined drug use, the relationship between antipsychotic polypharmacy as it relates to duration of hospitalization and re-hospitalization, and treatment compliance were evaluated in schizophrenia patients. The study data was obtained between January 1, 2017 and December 31, 2017 by examining the files of all patients who were hospitalized in Ondokuz Maps University Faculty of Medicine Hospital, Ankara Numune Training and Research Hospital, Ankara Gulhane Training and Research Hospital psychiatric services. The inpatients' drug prescriptions at discharge and after one-year outpatient follow-up, as well as treatment compliance and re-hospitalization, were examined. The mean duration of illness was 109.3 +/- 109.7 months, and the mean duration of hospitalization was 24.6 +/- 19.1 days. For a total of 599 patients, multiple antipsychotic medication was used in 21.2% of hospitalizations. 11.2% of patients using single antipsychotic and 14.2% of patients using multiple antipsychotics were re-hospitalized within one year (X-2 :0.830, p:0.362). Disease duration (Z:-3.654, p < 0.001) and duration of hospitalization (Z:3.333, p < 0.001) were found to be longer in multiple antipsychotic users. 37.8% of the patients used a depot antipsychotic. There was no significant difference between depot antipsychotic use and oral antipsychotic use as it related re-hospitalization rates. As a conclusion, multiple antipsychotic use has reduced in Turkey. Contrary to popular belief, the use of multiple antipsychotics does not shorten, but rather may prolongs hospitalization, and it has no effect in reducing re-hospitalization. Drug combinations are generally used together with a depot treatment, clozapine treatment is preferred less frequently in combinations, clinicians have proven effectiveness of the drug combination they prefer, and they should give priority to the treatments recommended in treatment guidelines.